chrisvoncsefalvay/vaers-outcomes huggingface dataset:
J96.00 ACUTE RESPIRATORY FAILURE 3/10/2022 HYPERLIPIDEMIA J96.10 CHRONIC RESPIRATORY FAILURE 2/18/2022 HYPERLIPIDEMIA J96.00 ACUTE RESPIRATORY FAILURE 3/10/2022 PALLIATIVE CARE J96.10 CHRONIC RESPIRATORY FAILURE 2/18/2022 PALLIATIVE CARE
Very Painful and swollen arm, hives from shoulder to under arm to the elbow, chills, low grade fever (99.8), weak, nauseous, general sick feeling. NO rapid heartbeat or throat swelling. Ice to arm, 50 mg of BENADRYL, then another 25 mg the next morning, lots of water, rest. Started to feel better after about 48 hours and by the 3 day, I felt pretty good.
3 weeks after vaccine the patient developed panic attack which then turned in to seizures. Patient was admitted and had complete workup and was diagnosed with Pseudoseizures.
I administered PNEUMOVAX 23 (right arm) and FLUAD (left arm) vaccinations to the patient. She called me the same day and told me that she was experiencing pain and redness on her right arm. She stated that the day of administration her arm hurt and she had trouble lifting it. She also experienced chills for two hours. Patient came in today to see me and told me her arm was feeling better but it was still a little red and warm to the touch. It has loosened up now and she has no trouble lifting it. She also stated that she had a reaction to a hydrocortisone shot she received a couple of months ago. The hydrocortisone shot caused her tingling and pain that eventually went away.
Dizziness, blurred vision, confusion/disorientation, weakness, pallor & diaphoresis immediately upon receiving injection. Quick recovery (10 mins) with no intervention necessary.
Redness swelling of arm at injection site, tenderness, and itching. (COVID arm)
[Summary Note: Right forearm cellulitis dx 2 days post AVA vaccination and 1 1/2 month post SMPX vac with reoccurrence right hand angioedema/urticaria up to 3 months later while deployed Feb-Aug 04 (no other site edema noted); @ 11 months post AVA vaccination c/o right cheek, lip, neck, hand and later foot edema, this is 2 months post TD and Influenza vaccinations 12/04 and three months post typhoid vaccination 11/05.]   Treated with prednisone tapers, benadryl, claritin, f/u allergy/immunology.  Symptoms persist prn as of 2006 Sept.
Patient is a 15 year old male, with athletic build, hx of occasional orthostatic hypotension, no LOC who developed fatigue, palpitations, persistent L sided chest pain, and worsening dizziness on day 2 after Pfizer COVID 19 vaccine #1(given 5/22/21). He was seen at an outside ER care on Day 3 post vaccine due to worsening symptoms, as per mom he had tachycardia in the ER visit,  was given tylenol, no ECG or labs at that time.  Given tylenol that day and told to take PRN.  Symptoms resolved rapidly after that.  No hx of heart disease, no fam hx of heart disease  No fam hx of sudden death less than 30
(trans frm Spanish by FV)pt says when left hosp, felt nausea, dizzy. Had to sit down, became pale, brought to hosp by ambulance, in ER was cold and pale
Immediately after vaccination, pt became pale and looked about ready to pass out. Patient's mother and I had pt keep head inbetween knees/put cold compress on forehead/back of neck. Pt. stated feeling light-headedness so we laid him on the floor/propped feet up and had him lie for 15min.  Patient said he felt better, gave him water and had him sit upright in chair for another 15min.    At that time after talking with mom regarding any previous history mom informed me of an episode of fainting when getting a blood draw for labs. I asked if patient had anything to eat and asked if he was well hydrated. Pt. responded he had not had anything to eat for awhile and were planning to eat after vaccination.  Regarding hydration patient said he did not drink much that day.  Mom feels it was due to anxiety/nerves.  I followed up with patient's mother 8-4-21 @ 9:20am.  She said patient was fine.  I suggested she contact pediatrician to discuss if MD advises pt. get 2nd dose.
No additional AEs; PEDVAXHIB and VAXNEUVANCE was administered to a patient after being improperly stored.; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. No information on patient medical history, current conditions and concomitant medications was provided.     On an unknown date the patient was vaccinated with improperly stored pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) lot # W036242 and expiration date 01-OCT-2024 (valid lot number) for prophylaxis (exact dose and route of administration were not provided) and also improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot# W028536 and expiration date 12-MAY-2025 (valid lot number) for prophylaxis (exact dose and route of administration were not provided) (experienced product storage error and no adverse event).
Acute onset of headache and severe brain fog with intermittent vertigo within hour of administration that persisted x 10 days with gradual daily improvement. Other side-effects were more typical with mild fever and chills (day 1 only), fatigue (severe at first, better by day 3), myalgia and arthralgia (severe at first, great improvement by day 3) and localized pain and swelling that turned to pruritus around day 5-7.
Starting 12/09/2022, I developed a lot of nasal congestion, a cough, very sore throat and a mild fever (99.5). I developed some mild chest congestion but it was mostly upper respiratory (sinuses). It lasted about 3 weeks. I contacted my doctor around 12/14/2022 and, after discussing the negative COVID-19 tests taken at home, I was prescribed antibiotics and told to use a nasal steamer and nasal rinse. He concluded I had a cold. I still had a deviated septum at this time which complicated things.
By error the nurse took the box that had a beyound use date of October 18, 2022 and administrated 6 doses to patients; Case reference number US-BN-2022-004306 is a spontaneous case received from other health care professional on 24-Oct-2022 via agency (reference: USBAV22-1762) and concerns a patient of unknown age and gender.  The patient's medical history and concomitant medications details were not provided.  On 21-Oct-2022, the patient vaccinated with Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: FPD00013, Expiration date: Sept-2024) at an unknown dose, through unknown route of administration, at unknown anatomical location, for monkeypox prophylaxis.  It was stated that, by error the nurse took the box that had a beyond use date of 18-Oct-2022 and administrated six doses to patients (explicitly coded as 'Expired vaccine used'). Vials were not punctured prior to administration.  At time of this report, the patients did not experience any adverse events as a result of Jynneos vaccination.  The reporter assessed causality between 'Expired vaccine used' and Jynneos as possibly related.  This case is linked with the cases US-BN-2022-004307, US-BN-2022-004308, US-BN-2022-004309, US-BN-2022-004310 and US-BN-2022-004311 (same reporter).  Additional information received on 24-Oct-2022 from Bavarian Nordic included local BN case ID.; Reporter's Comments: Six patients of unknown demographics were vaccinated with vials of Jynneos which were 3 days past the beyond-use date, which is considered expired product administered. No adverse events were reported. Expired product administered is considered listed per company convention. No medical history or concomitant medications information was reported. The event is considered not related to Jynneos, but to human error. The case is non-serious.; Sender's Comments: Six patients of unknown demographics were vaccinated with vials of Jynneos which were 3 days past the beyond-use date, which is considered expired product administered. No adverse events were reported. Expired product administered is considered listed per company convention. No medical history or concomitant medications information was reported. The event is considered not related to Jynneos, but to human error. The case is non-serious.
Patient stated she felt both hot and nauseated before vaccination and post vaccination. BP 124/74; HR 79; R 18; Temp 98.3; O2 Sat 99%. Provided water & juice. No respiratory distress AOx3. Pt reported symptoms resolved and had left arm pain. Patient deemed stable and released from vaccination site.
This spontaneous report was received from a 63 year old male physician via a field employee refers to himself. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not specified by the reporter. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX vial (dose, route of administration, lot# and expiration date were not reported) as a shingles vaccination. On an unknown date (reported as two weeks after receiving the dose of ZOSTAVAX, the patient developed a case of shingles (considered by the field employee as likely self-diagnosed by the physician). No treatment was given for the adverse event. The outcome of shingles was reported as recovered on an unspecified date. Causality assessment between ZOSTAVAX and the adverse event was not provided. Additional information has been requested.
Chest pain and SOB starting 12 hours after receiving vaccination. Extreme joint pain until 2 days after vaccination. Patient began to feel slightly better 3 days after vaccination. Chest pain lasted 12 hours. No chest pain on day 3.
4 days after vaccine dose, I started having pains that felt the same as when I was diagnosed with pericarditis prior. Pain under my left collar bone. It was mostly a sharp pain that was made much worse when taking a deep breath, or laying down. If I hadn't experienced this pain before, I may have gone to the emergency room. I was taking ibuprofen for the first week hoping that the pain would subside. I made a doctor appointment June 1 to be seen. The doctor didn't hear a pericardial rub, and prescribed Meloxicam for inflammation. At my 1 week follow up June 8, the pains had lessened, but were still present. The doctor gave me a prescription for Methylprednisolone, and after completing this round of steroids, the pain had gone away.
injection site swelling, edema, erythema Narrative: Pt started experiencing adverse event 8 days after receiving vaccine- injection site swelling, edema, erythema
Patient felt wiped out the next day but not as bad as the first two Moderna Covid-19 vaccine booster doses; I also had pain, redness, and a little swelling at the injection site; I also had pain, redness, and a little swelling at the injection site.; I also had pain, redness, and a little swelling at the injection site.; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first two Moderna Covid-19 vaccine booster doses), INJECTION SITE PAIN (I also had pain, redness, and a little swelling at the injection site), INJECTION SITE ERYTHEMA (I also had pain, redness, and a little swelling at the injection site.) and INJECTION SITE SWELLING (I also had pain, redness, and a little swelling at the injection site.) in a 68-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7644C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jul-2023, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In July 2023, the patient experienced INJECTION SITE PAIN (I also had pain, redness, and a little swelling at the injection site), INJECTION SITE ERYTHEMA (I also had pain, redness, and a little swelling at the injection site.) and INJECTION SITE SWELLING (I also had pain, redness, and a little swelling at the injection site.). On 21-Jul-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first two Moderna Covid-19 vaccine booster doses). At the time of the report, FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first two Moderna Covid-19 vaccine booster doses), INJECTION SITE PAIN (I also had pain, redness, and a little swelling at the injection site), INJECTION SITE ERYTHEMA (I also had pain, redness, and a little swelling at the injection site.) and INJECTION SITE SWELLING (I also had pain, redness, and a little swelling at the injection site.) outcome was unknown.            Concomitant medication not reported.   Treatment medication not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-748680, US-MODERNATX, INC.-MOD-2023-748686, US-MODERNATX, INC.-MOD-2023-748682 (Patient Link).
Pt received Vaccine on 8/8/17. Pt came today - 8/10/2017 - stating  she started having pain and swelling at site of injection that started on 8-9-17. Pt seen by provider and was given treatment plan and sent home.
R09.02 HYPOXIA 4/22/2023 COPD STAGE 3 SEVERE (FEV1 30-49%)
Roughly a month after the second shot I noticed more hair loss than normal.  I developed small bald patches on the back of my head and those turned into 3 large patches and patches starting to form at my front hairline.
Fever 102, rash fifty cents size around shot site saw MD; Father said it was a "longated rash way below inject site";
A report was received from a health care professional on 04Nov02 concerning a group of three vaccinees who experienced chills 5 days after receiving Fluvirin on 29Oct02. On 03Nov02 the vaccinees experienced chills 5 days after receiving 0.5ml Fluvirin IM. Vaccinees were residents of a long term care facility. The attending nurse felt that the chills should be investigated as possibly related to the vaccine although the attending physician was doubtful about this.
Patient experienced syncope, was sitting at time. Nurse laid table down and put cool cloths on patient, observed him for 15-20 mins until he felt better.
Sudden onset of severe headache, nausea, vomiting and blurred vision in one eye (one week after 2nd Pfizer shot) that required visit to Urgent care. Patient reported it was the most severe headache experienced to date. Patient tested positive for Influenza B and was sent home with instructions to go to Emergency room if headache returned.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date), PRODUCT STORAGE ERROR (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AR9236B) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 07-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date), PRODUCT STORAGE ERROR (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date) and PRODUCT STORAGE ERROR (Received a dose of the Moderna Covid 19 vaccine bivalent after the 30-day use by date, after the refrigerated beyond use date).
Dry heaves, loose stool, headache, body aches, fever (102), chills, sore arm, inflamed/sore lymph node in right armpit, sore throat (brief), and racing heart for first day.
Patient reports large blister to left arm, headache, fever, palpitations, sore throat, and fatigue Patient reports she took Oxycodone to help with discomfort with mild relief
Storage unit temperature excursion, vaccines deemed non viable by manufacturer. Contacting patient for re-vaccination.
shots given 1030AM pt slept 1030AM-1PM then cried relentlessly 1PM-6PM;temp not taken as mom stated pt doesn't feel hot;630PM was sleeping;MD prescribed APAP & cool pack
Had immunization in left thigh and developed large red swollen area (size of grapefruit) 24 hours after immunization.
In 1/00, the pt received his second dose of Lymerix. One month later, in 2/00, the pt experienced myalgias and rash. He was treated with pain medication. The most recent information received on 3/1/00 reports the condition of the pt as ongoing.
Total body aches. Sore musvles, sore at vaccination site, unable to perform daily activities
little pinches of aches here and there on his arms and legs; little body aches; Joint pain in my knees; nauseated/nauseated a little bit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little pinches of aches here and there on his arms and legs), PAIN (little body aches), ARTHRALGIA (Joint pain in my knees) and NAUSEA (nauseated/nauseated a little bit) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (little pinches of aches here and there on his arms and legs), PAIN (little body aches), ARTHRALGIA (Joint pain in my knees) and NAUSEA (nauseated/nauseated a little bit). At the time of the report, PAIN IN EXTREMITY (little pinches of aches here and there on his arms and legs), PAIN (little body aches), ARTHRALGIA (Joint pain in my knees) and NAUSEA (nauseated/nauseated a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Patient reports large subcutaneous nodule and tenderness at the vaccine site, continuing over 1 week following vaccination. Pain and swelling is improving. No other additional symptoms. Advised warm compress and OTC pain medications/NSAIDs as needed.
Patient came to pharmacy on 12/13/2020 to report that approximately 48 hours after the flu shot on 9/26/2020, he began to have mild arm pain. Over the next few months, the pain did not go away and has worsened over time to the point where his pain is bad and lifting his arm is difficult. He is going to his physician to have it evaluated on 12/14/2020 as per patient.
Slight headache; Brain fog; This is a spontaneous report received from a contactable consumer, the patient. A 47-Years old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) as a single dose via an unspecified route of administration in his right arm on 25Mar2021 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. The patients medical history was reported as none. Concomitant medications included regular vitamins and tamsulosin hydrochloride (FLOWMAX) received within 2 weeks of vaccination. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER6202) as a single dose via an unspecified route of administration in his right arm on 25Feb2021 at 17:00 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not tested for COVID-19. On 28Mar2021, the patient experienced slight headache and brain fog. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes for the events slight headache and brain fog were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
tired; headache; This is a spontaneous report from a contactable consumer. A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 05Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation (Age at vaccination: 62 years). Medical history included fibromyalgia. Concomitant medication included etanercept (ENBREL). The patient experienced tired and headache on 05Apr2021 12:00. The patient's hospitalization was prolonged as a result tired and headache on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: unknown on 13Apr2021. Patient is not pregnant. Outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.